- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 7, 2026 | 474.38M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 476.45M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 17.23M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$539.04K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$206.51K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $249.94M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $210.32M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $4.98M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $5.29M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $864.06K |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $652.75K |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.76M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.12M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $26.7M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $12.41M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $252.7M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $211.43M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.05 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.04 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $914.91K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $913.91K |
| Net Income | Q1 2026 · Mar 31, 2026 | $21.63M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$646.59K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$596.67K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$647.38K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $318.24K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $266.54K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $866.43K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $823.1K |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.18M |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.09M |
| Capex | Q1 2026 · Jun 14, 2025 | $250K |
| Capex | Q1 2026 · Jan 2, 2025 | $250K |